Kura oncology, inc. (KURA)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Operating Activities
Net loss

-19,210

-17,865

-16,392

-14,943

-13,940

-16,097

-15,007

-14,739

-14,604

-10,748

-9,333

-7,820

-7,533

-7,347

-6,926

-6,661

-6,626

-6,474

-6,090

-5,585

-4,476

-3,671

-6

-6

-5

-9

-6

-6

-5

-9

-6

-6

-5

-8

-6

-6

-5

Adjustments to reconcile net loss to net cash used in operating activities:
Share-based compensation expense

3,153

2,439

2,452

2,249

2,269

1,716

2,523

2,236

2,179

1,446

1,175

1,030

894

586

584

429

490

596

534

485

644

237

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense

-

-

-

-

-

17

53

57

57

56

30

16

16

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash license fee expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

500

500

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash accrued interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

37

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash accrued interest expense, related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

41

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation expense

-

-

-

-

-

0

1

4

5

7

7

8

8

8

8

7

8

7

7

3

3

1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of premium and accretion of discount on marketable securities, net

110

116

128

319

540

636

596

428

275

187

76

-22

19

-10

-16

-38

-65

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable, related party

1

-17

-64

-84

-45

-8

2

-27

41

7

-95

-37

46

34

-25

-120

-24

51

7

24

318

30

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

1,482

547

396

288

-146

-825

256

402

624

12

-278

53

409

-161

-159

-158

510

6

-134

114

664

42

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term assets

-160

-133

-71

139

182

149

313

-121

163

388

88

-171

288

429

274

23

-74

-

-

-

-

150

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term assets, related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses

-2,391

1,804

2,176

-1,059

-2,065

3,579

723

374

440

1,879

1,675

586

-1,088

497

856

215

-1,097

251

1,179

1,292

90

833

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-0

-1

-1

4

-1

-2

-2

-0

5

-1

-1

-1

5

-1

Accounts payable and accrued expenses, related party

-

-

-

-

-

-

-183

104

117

-

-55

-31

-342

-318

34

-141

258

-120

-55

51

927

135

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest, related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-36

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term liabilities

59

83

57

54

16

66

56

54

58

52

57

-38

147

-

-

-

-

-

-

-

-

1,307

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

4,290

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-8

2

7

0

-0

0

-6

4

1

0

-3

0

0

0

-1

1

Increase in accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

1

1

1

1

1

1

1

1

1

1

1

0

0

0

0

Increase in accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

0

-4

1

2

0

1

-4

4

0

0

-4

3

0

-2

-1

Net cash used in operating activities

-19,822

-13,933

-12,145

-14,431

-14,251

-10,211

-13,001

-12,592

-12,851

-

-

-

-

-

-

-

-

-

-

-

-

-12

-1

-1

-0

-4

-8

-9

-1

-0

-3

-14

-5

-1

-3

-15

-2

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-8,622

-6,738

-5,472

-5,825

-7,314

-5,605

-4,430

-3,767

-4,123

-849

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investing Activities
Maturities and sales of marketable securities

39,246

15,490

39,200

59,900

66,656

38,600

38,550

34,500

46,493

17,290

23,600

16,250

20,077

24,900

17,905

13,600

12,200

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-907

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of marketable securities

11,274

30,747

94,952

51,024

50,848

33,982

96,611

30,643

76,207

21,381

59,894

8,817

10,543

15,220

17,762

19,442

4,003

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property and equipment

511

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15

22

17

10

28

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by investing activities

27,461

-15,257

-55,752

8,876

15,808

4,618

-58,061

3,857

-29,714

-4,091

-36,294

7,433

9,534

9,680

143

-5,842

8,197

-40,448

-3,891

-26,277

-10

-28

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Financing Activities
Payments on notes payable, stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Proceeds from issuances of common stock, net

-

-

-

-

-

2

74,520

0

57,650

-

-

-

-

-

-

-

-

50,284

-255

-3,739

51,580

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Proceeds from exercise of stock options

247

-

-

-

102

-

-

-

-

-

187

30

5

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of convertible notes, related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

710

2,000

15

0

0

0

0

25

0

0

0

0

25

0

0

0

0

Proceeds from issuance of restricted stock awards

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

5

-

-

-

-

50,281

-252

-3,739

56,580

2,001

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

247

583

559

109,857

102

1,144

73,972

-125

57,650

-

-

-

-

-

-

-

-

-

-

-

-

0

15

0

0

0

0

25

0

0

0

0

25

0

0

0

0

Net increase in cash, cash equivalents and restricted cash

7,886

-28,607

-67,338

104,302

1,659

-4,449

2,910

-8,860

15,085

-11,903

11,182

1,512

917

2,942

-5,329

-4,214

883

4,228

-8,573

-33,783

52,447

1,124

13

-1

-0

-4

-8

15

-1

-0

-3

-14

19

-1

-3

-15

-2

Supplemental non-cash disclosures:
Conversion of convertible notes and related accrued interest to common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

4,327

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of convertible notes and related accrued interest to common stock, related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

3,288

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Financing costs included in accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,282

3,535

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-